Brought to you by:

Small Molecule Research and Development

Brought to you by:
weight loss GLP-1
Biotech

Ambrosia scores $100M series B to advance next-gen oral GLP-1

Ambrosia Biosciences is aiming to initiate a trial for its oral small-molecule GLP-1 therapy, backed by an oversubscribed $100 million series B round.
Will Maddox Mar 31, 2026 10:02am
Various shades of blue sewing thread spools

Amgen weaves in UK biotech with up to $840M acquisition

Jan 6, 2026 10:35am
person throwing away garbage or recycling

After $4.8B Amicus buy, BioMarin drops genetic disease asset

Dec 22, 2025 11:12am
sailing boat water yacht ocean wind

Voyager sets sail on neuro research trek with Transition Bio

Nov 10, 2025 5:23pm
hurdles

BridgeBio aces phase 3 rare disease test, clearing path to FDA

Oct 27, 2025 7:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Praxis plots path to FDA after phase 3 wins in essential tremor

Oct 16, 2025 11:48am